Related Experiment Video
Updated: Apr 10, 2026
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
Published on: June 15, 2021
From cardiac tissue engineering to heart-on-a-chip: beating challenges.
Yu Shrike Zhang1, Julio Aleman, Andrea Arneri
1Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA. Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Researchers review advances in cardiac tissue engineering and heart-on-a-chip models for heart regeneration and drug discovery. These biomimetic platforms, utilizing stem cell technology, offer personalized in vitro models for enhanced therapeutic development.
Area of Science:
- Biomedical Engineering
- Cardiovascular Biology
- Regenerative Medicine
Background:
- The heart's vital role in nutrient supply and waste removal is crucial for homeostasis.
- Cardiac tissue engineering aims to regenerate heart function using biomimetic approaches.
- Recent progress integrates tissue engineering with microfluidic heart models for drug discovery.
Purpose of the Study:
- To review recent advances in engineering functional cardiac tissues.
- To explore the development of heart-on-a-chip platforms for drug screening and regeneration.
- To discuss characterization techniques and personalization potential of cardiac models.
Main Methods:
- Review of biomimetic approaches in cardiac tissue engineering.
- Integration of stem cell technologies for personalized in vitro models.
- Development of microfluidic heart-on-a-chip platforms.
Main Results:
- Significant progress in engineering functional cardiac tissues.
- Emergence of physiologically relevant heart-on-a-chip models for drug discovery.
- Advancements enabling personalized in vitro cardiac models.
Conclusions:
- Cardiac tissue engineering and heart-on-a-chip platforms are advancing heart regeneration.
- These models are valuable for cardiotoxic/cardiotherapeutic drug screening.
- Characterization and personalization hold significant potential for future cardiac research.
More Related Videos
11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
09:35Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020